Forget Aurora Cannabis, a Top Analyst Says Buy These 5 Pot Stocks Instead
Not long ago, Aurora Cannabis (NYSE: ACB) ranked as the darling of Wall Street analysts. But analysts can be quite fickle. Bank of America Merrill Lynch's Christopher Carey downgraded Aurora from buy to neutral in July. Now another top analyst has expressed a lack of confidence in Aurora's prospects.
Earlier this week, Piper Jaffray initiated coverage on Aurora with a neutral rating. However, the investment firm hasn't given up on the cannabis sector. Although Piper Jaffray doesn't recommend buying Aurora Cannabis, there are five pot stocks the firm does like right now.
Image source: Getty Images.
Source Fool.com
